6-K 1 ambevsacvm358nov20_6k1.htm AMBEVSACVM358NOV20_6K1
 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM 6-K
 
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 of the
Securities Exchange Act of 1934
 
For the month of December, 2020

Commission File Number 1565025
 
 

AMBEV S.A.
(Exact name of registrant as specified in its charter)
 

AMBEV S.A.
(Translation of Registrant's name into English)
 

Rua Dr. Renato Paes de Barros, 1017 - 3rd Floor
04530-000 São Paulo, SP
Federative Republic of Brazil
(Address of principal executive office)
 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. 


Form 20-F ___X___ Form 40-F _______

 Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.  

Yes _______ No ___X____

 
 

CONSOLIDATED FORM

Management and Related Persons’ Transactions of Securities Issued by the Company

Article 11 - CVM Instruction # 358/2002

 

From November 1st to 30th, 2020 the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002:

 

Company Name: Ambev S.A.  
Group and Related Persons

( X )

Board of Directors

( )

Management

( )

Fiscal Council

( )

Technical and Consulting Committees

 
Initial Balance  
Securities / Derivatives Securities Characteristics (2) Quantity  
 
Shares Common 32,300,347  
ADR Common 1,068,738  
Transactions in the month  
Securities / Derivatives Securities Characteristics (2) Intermediary Operation Day Quantity Price Volume (R$) (3)  
                 
Final Balance  
Securities / Derivatives Securities Characteristics (2) Quantity  
 
Shares Common 32,300,347  
ADR Common 1,068,738  
                         

 

 

 

 
 

CONSOLIDATED FORM

Management and Related Persons’ Transactions of Securities Issued by the Company

Article 11 - CVM Instruction # 358/2002

 

From November 1st to 30th, 2020 the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002:

 

 

Company Name: Ambev S.A.  
Group and Related Persons

( )

Board of Directors

( X )

Management

( )

Fiscal Council

( )

Technical and Consulting Committees

 
Initial Balance  
Securities / Derivatives Securities Characteristics (2) Quantity  
 
Shares Common 5,128,911  
ADR Common 268,126  
Transactions in the month  
Securities / Derivatives Securities Characteristics (2) Intermediary Operation Day Quantity Price Volume (R$) (3)  
Shares Common Direct with Company Exerc Options 30 97,000 9.35960 907,881.20  
Shares Common Direct with Company Exerc Options 30 57,225 9.35960 535,603.11  
Final Balance  
Securities / Derivatives Securities Characteristics (2) Quantity  
 
Shares Common 5,283,136  
ADR Common 268,126  
                           

 

 

 
 

CONSOLIDATED FORM

Management and Related Persons’ Transactions of Securities Issued by the Company

Article 11 - CVM Instruction # 358/2002

 

 

From November 1st to 30th, 2020 the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002:

 

Company Name: Ambev S.A.  
Group and Related Persons

( )

Board of Directors

( )

Management

( X )

Fiscal Council

( )

Technical and Consulting Committees

 
Initial Balance  
Securities / Derivatives Securities Characteristics (2) Quantity  
 
Shares Common 0  
Transactions in the month  
Securities / Derivatives Securities Characteristics (2) Intermediary Operation Day Quantity Price Volume (R$) (3)  
                 
Final Balance  
Securities / Derivatives Securities Characteristics (2) Quantity  
 
Shares Common 0  
                           

 

 

 

 
 
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
Date: December 10, 2020
     
 
AMBEV S.A.
     
 
By: 
/s/ Lucas Machado Lira
 
Lucas Machado Lira
Chief Financial and Investor Relations Officer